Valeo Pharma (VPH) Earnings Date, Estimates & Call Transcripts

C$0.10
-0.01 (-8.70%)
(As of 10:19 AM ET)

Earnings Summary

Upcoming
Earnings Date
Jun. 11Estimated
Actual EPS
(Mar. 14)
-C$0.08
Consensus EPS
(Mar. 14)
-C$0.08
Skip Charts & View Estimated and Actual Earnings Data

VPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VPH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Valeo Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241C($0.08)C($0.08)C($0.08)
Q2 20241C($0.06)C($0.06)C($0.06)
Q3 20241C($0.04)C($0.04)C($0.04)
Q4 20241C($0.03)C($0.03)C($0.03)
FY 20244C($0.21)C($0.21)C($0.21)

VPH Earnings Date and Information

Valeo Pharma last released its earnings data on March 14th, 2024. The reported C($0.08) earnings per share for the quarter, meeting analysts' consensus estimates of C($0.08). The company earned C$13.54 million during the quarter, compared to analyst estimates of C$15.30 million. Valeo Pharma has generated C($0.32) earnings per share over the last year (C($0.32) diluted earnings per share). Valeo Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, June 11th, 2024 based off prior year's report dates.

Valeo Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/11/2024
Estimated)
------- 
3/14/2024Q1 2024C($0.08)C($0.08)-C($0.08)C$15.30 millionC$13.54 million
1/29/2024Q4 2023C($0.05)C($0.10)C($0.05)C($0.10)C$16.50 millionC$13.11 million
9/13/2023Q3 2023C($0.06)C($0.07)C($0.01)C($0.07)C$16.10 millionC$14.08 million
6/13/2023Q2 2023C($0.07)C($0.08)C($0.01)C($0.08)C$13.60 millionC$13.56 million
3/15/2023Q1 2023-C($0.08)C($0.08)C($0.08)-C$13.16 million
1/30/2023Q4 2022-C($0.11)C($0.11)C($0.11)-C$12.66 million
9/13/2022Q3 2022-C($0.06)C($0.06)C($0.06)-C$6.07 million
6/14/2022Q2 2022-C($0.06)C($0.06)C($0.06)-C$4.77 million
3/24/2022Q1 2022-C($0.07)C($0.07)C($0.07)-C$4.24 million
2/28/2022Q4 2021-C($0.10)C($0.10)C($0.10)-C$3.38 million
9/22/2021Q3 2021-C($0.04)C($0.04)C($0.04)-C$5.67 million
6/29/2021Q2 2021-C($0.03)C($0.03)C($0.03)-C$2.65 million

Valeo Pharma Earnings - Frequently Asked Questions

When is Valeo Pharma's earnings date?

Valeo Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, June 11th, 2024 based off last year's report dates. Learn more on VPH's earnings history.

Did Valeo Pharma beat their earnings estimates last quarter?

In the previous quarter, Valeo Pharma (TSE:VPH) reported C($0.08) earnings per share (EPS) to hit the analysts' consensus estimate of C($0.08). Learn more on analysts' earnings estimate vs. VPH's actual earnings.

How much revenue does Valeo Pharma generate each year?

Valeo Pharma (TSE:VPH) has a recorded annual revenue of C$54.29 million.

How much profit does Valeo Pharma generate each year?

Valeo Pharma (TSE:VPH) has a recorded net income of -C$28.43 million. VPH has generated -C$0.32 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (TSE:VPH) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners